Suppr超能文献

麸质含量在标签和未标签的无麸质食品产品中使用的乳糜泻患者。

Gluten content in labeled and unlabeled gluten-free food products used by patients with celiac disease.

机构信息

Department of Gastroenterology and Human Nutrition, All India Institute of Medical Sciences, New Delhi, India.

Department of Home Science, University of Delhi, New Delhi, India.

出版信息

Eur J Clin Nutr. 2021 Aug;75(8):1245-1253. doi: 10.1038/s41430-020-00854-6. Epub 2021 Jan 18.

Abstract

OBJECTIVE

Gluten-free (GF) diet is the only reliable treatment for patients with celiac disease (CeD), but data on the extent of gluten contamination in GF food available in India is scanty. We evaluated gluten content in labeled, imported, and non-labeled GF food products currently available in the Indian market.

METHODS

Overall, 794 processed and commercially available packaged GF products (labeled GF (n = 360), imported GF (n = 80), and non-labeled/naturally GF (n = 354)) were collected from supermarkets of National Capital Region of India. Those unavailable in stores were purchased from e-commerce sites or directly from the manufacturers. Gluten level in them was determined by Ridascreen Gliadin sandwich R5 enzyme-linked immunosorbent assay (R-Biopharm AG, Germany). As per Codex Alimentarius and Food Safety and Standard Authority of India, "gluten free" labeled products must not contain > 20 mg/kg of gluten.

RESULTS

Overall, 10.1% of 794 GF products including 38 (10.8%) of 360 labeled and 42 (11.8%) of 354 non-labeled/naturally GF food products had gluten content > 20 mg/kg (range: 24.43-355 and 23.2-463.8 mg/kg, respectively). None of the imported GF products had gluten more than the recommended limits. Contaminated products most commonly belonged to cereal and their products (flours, coarse grains, pasta/macaroni, snack foods) pulse flours, spices, and bakery items.

CONCLUSIONS

A substantial proportion (10.1%) of GF food products (both labeled and non-labeled) available in India have gluten content greater than the prescribed limits of <20 mg/kg. Physicians, dietitians, support group, and patients with CeD should be made aware of this fact and regulatory bodies should ensure quality assurance.

摘要

目的

无麸质(GF)饮食是乳糜泻(CeD)患者的唯一可靠治疗方法,但关于印度 GF 食品中麸质污染程度的数据很少。我们评估了目前在印度市场上可获得的标签、进口和非标签 GF 食品产品中的麸质含量。

方法

总体而言,从印度国家首都地区的超市收集了 794 种加工和市售的包装 GF 产品(标签 GF(n=360)、进口 GF(n=80)和非标签/天然 GF(n=354))。那些在商店中不可用的产品是从电子商务网站或直接从制造商处购买的。它们的麸质含量通过 Ridascreen 谷蛋白夹心 R5 酶联免疫吸附试验(R-Biopharm AG,德国)确定。根据食品法典和印度食品安全和标准管理局的规定,“无麸质”标签产品不得含有>20mg/kg 的麸质。

结果

总体而言,794 种 GF 产品中有 10.1%,包括 360 种标签中的 38 种(10.8%)和 354 种非标签/天然 GF 食品中的 42 种(11.8%)产品的麸质含量>20mg/kg(范围分别为 24.43-355 和 23.2-463.8mg/kg)。没有一种进口 GF 产品的麸质含量超过建议的限量。受污染的产品最常见于谷物及其制品(面粉、粗粮、意大利面/通心粉、零食、豆类粉、香料和烘焙食品)。

结论

印度市场上相当一部分(10.1%)的 GF 食品(包括标签和非标签)的麸质含量超过规定的<20mg/kg 限量。乳糜泻患者的医生、营养师、支持团体和患者应该意识到这一事实,监管机构应确保质量保证。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验